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A novel method is described for the preparation of sterile submicron unilamellar liposomes. The method is based on the lyophilization of
double emulsions containing disaccharides as lyoprotectants in both the inner and outer aqueous phase. Using various phospholipids or mixtures
of lipids as emulsifiers, the double emulsions can be prepared by a two-step emulsification, including hydrophilic agents in the inner aqueous
phase or lipophilic agents in the oil phase. Then, the double emulsions are lyophilized after sterilization by passing them through a 0.22-μm pore
filter. Rehydration of the lyophilized products results in liposomes with a relatively high encapsulation efficiency (for calcein, 87%; 5-fluorouracil,
19%; flurbiprofen, 93%) and a size below 200 nm measured by the dynamic light scattering technique (DLS) and the atomic force microscopy
(AFM). The liposomes were found to be unilamellar from freeze-fracture electron micrographs and X-ray diffraction patterns. In addition, the
liposomes can be reconstituted just before use by rehydration of the lyophilized products which are relatively stable. Thus, this reproducible and
simple technique can be used to prepare sterilized, submicron unilamellar liposomes with a relatively high encapsulation efficiency, and excellent
stability during long-term storage.
© 2006 Elsevier B.V. All rights reserved.Keywords: Liposome; Preparation; Freeze-drying; Double emulsion; Encapsulation efficiency; Particle size1. Introduction
Liposomes, vesicles enclosing an aqueous solution with
membranes of phospholipids, have been extensively studied as
microparticulate carriers for the efficient delivery of therapeutic
agents since the first report by Bangham et al. [1,2]. The
superiority of liposomes as drug carriers is now widely
recognized and great advances in the liposome field have
resulted in the development of some approved liposomal
products [3]. However, it is still not easy to prepare acceptable
aseptic liposomal drugs with desirable properties, high
encapsulation efficiency, and long-term stability without drug
leakage and loss [4,5].
When liposomes are used as drug carriers, their size is of
major importance, since this influences the behavior of
liposomes in biological systems [6]. In order to extravasate⁎ Corresponding author. Tel./fax: +86 24 23917603.
E-mail address: artinwon@yahoo.com.cn (Y. Deng).
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doi:10.1016/j.bbamem.2006.01.023into the disease site, the liposomes should be smaller than
120 nm. This requires very efficient loading, otherwise, either
therapeutic levels of drug cannot be reached or a very large
amount of lipids is needed to obtain these levels. Furthermore,
inefficient loading will lead to a great loss of the active agent
during loading and complicate the preparation procedure by
making it difficult to remove the free agent [5].
As liposomes are usually made of phospholipids which are
susceptible to light, heat and oxygen, it is usually not acceptable
to sterilize the products for parenteral use by autoclaving.
Furthermore, when liposomes exist in aqueous solutions, they
may be subject to a series of adverse effects such as aggregation,
fusion, phospholipid hydrolysis, and drug leakage, which lead
to a short-shelf life [4].
Many efforts have been made to improve the properties of
liposomal preparations, especially the encapsulation efficiency,
vesicle size, and stability, which are still major problems
standing in the way of new advances in this field [5]. Up to now,
a number of different methods have been successfully
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be classified for convenience into three categories based on the
dispersion technology [7]: (1) mechanical dispersion methods,
for example, hand shaking, or vortexing, sonication, and the use
of a French press; (2) detergent-solubilizing dispersion methods
including solubilizing lecithin with sodium cholate or octylglu-
coside; (3) solvent dispersion methods, such as ethanol
injection, ether infusion, and reverse-phase evaporation
(REV). Liposomes prepared by the REV method are known
to have a higher encapsulation efficiency for water-soluble
agents than those prepared by other methods. However, the
REV vesicles usually have a diameter larger than 200 nm [8].
Some measures, such as extrusion and sonication, used to
control the vesicle size [9–11] are likely to lead to drug loss. A
novel liposomal technology involving freeze-drying of a
monophase solution, developed in our lab, can produce stable
freeze-dried products that can form submicron liposomes with a
narrow size distribution upon rehydration [12]. However, this
method results in a low encapsulation efficiency unless it is
combined with active loading.
The active loading, namely remote loading of the agents
into preformed liposomes by the use of special gradients
across the liposome membranes, such as pH gradients
[13,14] and ammonium salt gradients [15], can result in a
rather high encapsulation efficiency; but it limits the
liposomal entrapment to only certain ionizable hydrophilic
or amphipathic agents. Another way of loading the agents
into preformed liposomes involves the dehydration–rehydra-
tion of a mixture of liposomes and the materials to be
loaded, and the final liposomes formed, so called DRVs, can
entrap up to 80% of the starting materials which can be
labile molecules, such as proteins, peptides and nucleic
acids. However, the DRVs are usually large multilamellar
vesicles [16,17].
In order to improve the stability, studies have been carried
out and confirmed that liposomes can be effectively stored in
the dried state by lyophilization in the presence of carbohydrates
as lyoprotectants [18]. Usually, this lyophilization practice
needs multiple-step entrapment procedures for preparing drug-
containing liposomes.
In this report, a novel procedure is presented for the
preparation of sterile unilamellar liposomes with the
desirable properties of a relatively high encapsulation
efficiency and a mean diameter less than 200 nm. The
methodology includes preparation of agent-containing double
emulsions with disaccharides as lyoprotectants in both the
inner and outer aqueous phase, sterilization by passage
through a 0.22-μm pore filter, lyophilization to remove
solvents, and rehydration to obtain an aqueous suspension of
liposomes. Also, the methodology has the advantage of
allowing complete removal of organic solvents and the
preparation of stable dry products which can be rehydrated
just before use allowing enhanced storage stability. This
approach has been validated for the encapsulation of both
hydrophilic and lipophilic agents in vesicles to form a
product that would be suitable as an effective carrier for the
efficient delivery of therapeutic agents.2. Materials and methods
2.1. Materials
Soybean phosphatidylcholine (PC, Epikuron 200, purity >92%) and
soybean phosphatidylserine (PS, Leci-PS90PN, purity >95%) were generous
gifts from Degussa (Freising, Germany). Calcein (Cal) was purchased from
Sigma (St. Louis, MO, USA ). Cholesterol (CH) was of analytical grade
from Tianjin Chemical Reagent Co. Inc (Tianjin, China). Flurbiprofen (Flu)
was obtained from Southwest Synthetic Pharmaceutical Co., Ltd. (Chongq-
ing, China) and 5-fluorouracil (5-Fu) was a product of Jiangsu Jintan
Pharmaceuticals (Jintan, China). The solvents used for the chromatographic
mobile phases were of HPLC grade. All other chemicals were of analytical
reagent grade.
2.2. Preparation of liposomes by freeze-drying double emulsions
(FDE)
The W1/O/W2 double emulsions were prepared by a two-step emulsification
procedure at room temperature (25 °C). Several organic solvents (or mixed solvents)
which are immiscible with water, such as ether, chloroform, can be used as the oil
phase (O), but cyclohexanewas selectively used because its melting point is near that
of water. Distilled water was used for the aqueous phase (W). Sucrose (Suc) , lactose
(Lac), and sucrose together with mannitol (Man) were used, respectively, as
lyoprotectants dissolved in both the inner aqueous phase (W1) and the outer aqueous
phase (W2) at a concentration of 5% (w/v). Eachmodel agent was dissolved either in
the oil phase (O) or in the inner aqueous phase (W1). Concentrations of the drug
solutions used in this study were as follows: calcein, 66.65μg/ml (0.1 mM) in water;
5-fluorouracil, 1.0 mg/ml (7.7 mM) in water; flurbiprofen, 1.2 mg/ml (5.0 mM) in
cyclohexane. The phospholipids were dissolved in cyclohexane to give 2.5% (w/v)
(ca. 0.033 mol l−1) solutions of lipid mixture solution. The mass ratio of lipids to
lyoprotectants in the final aqueous suspensions of liposomes was 1:5.
2.2.1. Formation of W1/O/W2 double emulsions and sterile filtration
Two milliliters of each lipid mixture solution (O) and 1 ml of aqueous
solution (W1) were added to a 10-ml ampoule, and this mixture was then
emulsified with a homomixer ( Ultra Turrax®, model T18, IKAWorks, USA) at
22,000 rpm for 30 s to form 3 ml of W1/O type emulsions (primary emulsions).
The primary emulsions were immediately sonicated briefly (200 w, ca. 3 min)
with a probe-type sonicator (JY92-2D Sonicator, Xinzhi Biotech. Co, Ltd.
Ningbo, China) until the mixture became either clear or a uniformly opalescent
microemulsion that did not separate for at least 30 min after sonication. The
temperature was kept under 25 °C using a water bath during sonication. The
microemulsions were then mixed with 4 ml aqueous solution (W2), and
emulsified at 18,000 rpm for 30 s to form mostly the type A of W1/O/W2 double
emulsions, namely containing only one internal aqueous droplet [19]. The
double emulsions were sterilized by passage through a 0.22-μm filter, then
immediately transferred to 5-ml freeze-drying vials with a fill volume of 2 ml
and at once frozen.
2.2.2. Freeze-drying
The freeze-drying process was as follows: (1) freezing at −50 °C for 8 h; (2)
primary drying −50 °C for 48 h; and (3) secondary drying at 25 °C for 24 h. The
chamber pressure was maintained at 20 pascals during the drying process. When
the freeze-drying process was over, the vials were immediately filled with
nitrogen gas, sealed with rubber caps, and stored at 4 °C.
2.2.3. Reconstitution
When needed, aqueous suspensions of liposomes were immediately formed
upon rehydration of the lyophilized products with water to the original volume.
2.3. Characterization of the liposomes
2.3.1. Dynamic light scattering technique
The mean diameters of the liposomes in aqueous solution were determined
by the dynamic light scattering technique (DLS) with a submicron particle size
analyzer (Ls23, Beckman, USA) [20].
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Atomic force microscopy (AFM) measurements were made at room
temperature (20 °C), using a commercial atomic force microscope (SPI3800N
Probe Station and SPA-400 SPM Unit, Seiko Instruments, Japan). A tapping
mode liquid cell was used to obtain images of liposomes in pure water.
Cantilevers with tips (SI-DF3, Seiko Instruments, Japan) with a nominal spring
constant of 2 N/m were used. The cantilevers were acoustically excited
indirectly both through the cell and the liquid at frequencies of 9 kHz, which is
just below their resonant frequency in water. Scan rates were 1 Hz with a pixel
number of 256×256. Just before the analysis, the samples were rehydrated and
aliquots of 20 μl liposome solution were deposited on mica. After 1 min, the
mica was gently rinsed with pure water, and the sample chamber was mounted
onto the AFM scanner and the measurements were performed and completed
within a few minutes to avoid deformation [21].
2.3.3. Freeze-fracture electron microscopy
The freeze-fracture electron micrographs were obtained as described
elsewhere [22], and a freeze-fracture device (Balzers BAF 400D) was used
for fracturing.
2.3.4. X-ray diffraction
2.3.4.1. Determination of lamellarity. X-ray diffraction data were collected
by diffractometer (D-max 2400, Rigaku, Japan). Samples were exposed to a
monochromatic beam with a wavelength of 1.5418 Å, which was produced by
bombarding copper with electrons. The scanning was performed from 1.00 to
10.00°, in steps of 0.02°/s at room temperature.
Five samples were analyzed and all involved PS/PC (1:9) with sucrose as
lyoprotectant and a lipid/sucrose weight ratio of 1:5. Sample 1 was the
lyophilized multilamellar vesicles (MLVs). TheMLVs were prepared as follows:
first, the lipid film was hydrated with a 5% (w/v) sucrose solution to obtain a 1%
(w/v) liposome suspension and then this suspension was extruded 10 times
through 0.8-μm pores using a 10-ml thermobarrel extruder (Northern Lipids
Inc., Vancouver, Canada). Sample 2 was the lyophilized large unilamellar
vesicles (LUVs). LUVs were prepared in the same way as sample 1, except that
the sizing process was performed using 100-nm membranes. Sample 3 was the
powder of FDE. Sample 4 was prepared as follows: first, a replica of sample 3
was hydrated to obtain an aqueous suspension of liposomes, and then
lyophilized. Sample 5 was a solid dispersion of lipids in sucrose matrix which
was obtained by freeze-drying tert-butyl alcohol/water cosolvent systems
containing lipids and water-soluble materials [12] and this was used as a control.
2.3.4.2. Examination of the lyoprotectant phase. Two samples of the powder
of FDE composed of PS/PC (1:9) with lyoprotectants of, respectively, sucrose
and sucrose together with mannitol (1:1,w/w), were tested by X-ray
diffractometry, and scanning was performed from 3.0 to 45.0°, in steps of
0.04°/s at room temperature.
2.3.5. Determination of encapsulation efficiency and entrapped volume
The encapsulation efficiency (EE) for calcein and the entrapped volume
(EV) based on calcein were determined according to the method described by
Oku et al. [23]. Briefly, the liposome suspension was diluted 50-fold with
aqueous solution containing 5% (w/v) lyoprotectants, and 2 ml of the diluted
liposome suspension was used to measure the fluorescence intensity of calcein
before (Ftot) and after (Fin) addition of 50 μl of CoCl2 (1.0 mM) on a fluorometer
(F-931; Shanghai Spectroscopic Co, Ltd. China) at excitation and emission
wavelengths of 400 and 520 nm, respectively. Subsequently, 100 μl 10% (w/v)
TritonX-100 was added and the fluorescence was measured again and the
resultant fluorescence intensity (Fr) represents the equilibrium concentration of
the free calcein. The EE and EV were calculated from:
EEð%Þ ¼ ðFind r1  Frd r2Þ=ðFtot  Frd r2Þ  100 ¼ EVð%Þ ð1Þ
where r1 and r2 were the dilution factors due to the addition of CoCl2 solution
and Triton X-100 solution, in the present case, 1.025, 1.075, respectively.
For 5-fluorouracil, the EE was estimated from the following equation:
EEð%Þ ¼ ðDtot  DfreeÞ=Dtot  100 ð2Þthe free drug (Dfree) was separated by ultrafiltration through a Millipore filter
(Amico8010, Millipore Corporation, Bedford, USA) and assayed spectropho-
tometrically at a wavelength of 265 nm. The total content of drug (Dtot) in the
preparations was determined after the liposome suspension was diluted with
appropriate methanol to disrupt the liposomes completely and release the
encapsulated drugs into the solvents.
The EE for flurbiprofen was calculated from the following equation:
EEð%Þ ¼ Den=Dtot  100 ð3Þ
the amount of flurbiprofen encapsulated in the liposomes (Den) was
determined by HPLC (LC-10AT liquid chromatograph, SPD-10A UV
detector, Shimadzu, Kyoto, Japan) at a UV detection wave-length of
222 nm after the liposomes were separated from the extra aqueous solution
by ultracentrifugation at 20 000×g for 15 min and the pelleted vesicles were
dissolved in an appropriate amount of methanol. The mobile phase was
methanol/water/acetic anhydride (70:30:0.1, v/v/v).
2.4. Detection of solvent residue
Analyses of the solvent residue in the freeze-dried products were carried out
on a gas chromatograph (GC-2010 Gas Chromatograph, Shimadzu, Japan) with
an FID detector according to reference [24].
2.5. Stability test
The stability of the dried products was assessed by determination of the
liposomes, which were reconstituted from dried products protected from light at
4 °C for different periods of time, using the changes in encapsulation efficiency
and mean diameters as described above.3. Results
3.1. Vesicle size
Examination of FDE vesicles composed of different lipids
containing different agents by DLS revealed that the mean
diameters were all under 200 nm. The mean diameters of FDE
vesicles composed of PS/PC (1: 9) were smaller than those of
other formulations. Table 1 provides details of the test results.
AFM micrograph of the PS/PC (1:9) FDE liposomes
containing calcein with lyoprotectants of sucrose and mannitol
revealed that the sizes of the vesicles were under 150 nm and the
mean diameters was 92 nm, in good agreement with data
obtained by DLS. Representative AFM topography and phase
images of the PS/PC (1:9) FDE liposomes are shown in Fig. 1.
The AFM topography image and the cross-section given in Fig.
2 suggested that the FDE liposomes were nearly spherical and
little deformation had taken place after sample deposition on the
mica.
3.2. Freeze-fracture electron micrograph
The FDE liposomes were shown to be unilamellar vesicles
from the freeze-fracture electron micrographs presented in
Fig. 3.
3.3. X-ray diffraction
It has been shown that solid state lipids obtained from
lyophilization (or from film deposition) spontaneously form
Table 1
Effects of lipid composition and lyoprotectants on the size, encapsulation efficiency and trapped volume of FDE liposomes (n = 3)
Lipid composition
(1%, w/v) a
Sugar
(5%, w/v) a
Mean diameters (nm) Encapsulation efficiency (%) Trapped volume
(based on Cal)
(μl/mg)
Cal 5-Fu Flu Cal 5-Fu Flu
PC Suc 112 116 112 69.2 16.1 91.4 6.92
Lac 131 145 142 62.6 14.4 90.3 6.26
Suc+Man b 114 117 118 67.5 15.9 92.7 6.75
PS/PC (1:9) c Suc 98 97 102 78.4 17.9 90.9 7.84
Lact 110 108 112 73.5 16.4 89.3 7.35
Suc+Man b 96 95 110 76.6 17.1 91.4 7.66
PS/PC/CH (1:4:5) c Suc 147 152 157 87.6 19.6 93.2 8.66
Lac 183 189 197 80.4 18.1 92.8 8.04
Suc+Man b 145 149 158 86.7 19.4 93.8 8.77
Abbreviations: Cal, calcein; 5-Fu, 5-fluorouracil; Flu, flurbiprofen; CH, cholesterol; Suc, sucrose; Lac, lactose; Man, mannitol.
a The concentration in the final aqueous suspension of liposomes.
b Sucrose and mannitol were in a mass ratio of (1:1).
c Mole ratio of different lipids.
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there is similar lamellar structure to that of unilamellar or
multilamellar vesicles in the lyophilized products, two controlsFig. 1. Representative taping mode AFM topography and phase images of PS/
PC (1:9) FDE liposomes, panels a and b, respectively. The AFM measurements
were performed immediately after sample deposition on a mica surface in pure
water. The liposomes were reconstituted just before AFM tests by rehydration of
lyophilized double emulsions containing calcein and lyoprotectants sucrose and
mannitol.were used: one was the lyophilized MLVs, which contained
stacked lamellae, and the other was the lyophilized LUVs,
which provided diffraction information on unilamellar vesicles.
The small angle X-ray diffraction patterns are presented in
Fig. 4. Characteristically different diffraction patterns are ob-
tained from unilamellar vesicles and from regularly stacked bi-
layers of multilamellar vesicles. For unilamellar vesicles, where
the bilayers have no fixed geometrical relationship to each other,
the diffraction pattern displays a very broad peak, which can be
used to roughly estimate the bilayer thickness. On the other hand,
the regularly stacked bilayers will display a relatively sharp peak
[26]. As seen from Fig. 4, the lyophilized MLVs (Sample 1)
showed a lamellar repeat spacing of about 58.1 Å (λ=1.5418 Å,
2θ=1.52°). The lyophilized LUVs (Sample 2), with an average
size of 100 nm, displayed a relatively broad diffraction pattern.
Sample 4 had a similar diffraction pattern to that of Sample 2,
which means that the FDE liposomes are not multilamellar.
Also, the lyophilized products of FDE (Sample 3) exhibited a
similar diffraction pattern to that of Sample 2. Thus, the lyo-
philized products of FDE appear to possess similar single
bilayers to those of LUVs. Obviously, Sample 5 exhibited a
diffraction pattern different to those of all the other samples,
since it had no similar structure to that of MLVs or LUVs [12].
Fig. 5 shows the lyoprotectant of sucrose represented as
vitrification in the powder of FDE, while mannitol was in
crystalline form.
3.4. Encapsulation efficiency
The encapsulation efficiency of FDE vesicles depends on the
lipid composition, lyoprotectants, and the properties of the
trapped agents. With sucrose as a lyoprotectant, the FDE
liposomes composed of PS/PC/CH (1:8:9) exhibited the highest
encapsulation efficiency (Table 1).
3.5. Calculation of the expected diameters
This calculation is based on the assumptions: that the
captured aqueous volume of the FDE liposomes equals that of
the double emulsions (W1) from which the former are formed; a
Fig. 2. A taping mode AFM topography image including the height cross-section indicated by the straight line. The AFMmeasurements of PS/PC (1:9) FDE liposomes
were performed immediately after deposition on a mica surface in pure water. The liposomes were reconstituted just before AFM tests by rehydration of lyophilized
double emulsions containing calcein and lyoprotectants sucrose and mannitol.
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58 Å2 in the presence of cholesterol; and a uniform population
of spherical unilamellar vesicles of diameter:
D ¼ 12V=A ð4Þ
where V is the total encapsulated volume, and A is the total
surface area of a lipid monolayer; the actual thickness of theFig. 3. Typical freeze-fracture electron micrographs of the FDE liposomes. (a)
The liposomes were composed of PC with lyoprotectants sucrose and mannitol
(1:1, w/w). (b) The liposomes were composed of PS/PC (1: 9) with sucrose as
the lyoprotectant. Scale bar indicates 100 nm.lipid bilayer and any difference in surface area between inside
and outside monolayers have not been taken into account [8].
Calculations based on the entrapped volume of FDE vesicles
composed respectively of PC, PS/PC (1:9), and PS/PC/CH
(1:8:9) (shown in Table 1) gave values of 145 nm, 165 nm and
207 nm respectively, which are in good agreement with the
values obtained by AFM and DLS. The agreement between the
calculated and observed diameter values, as well as the freeze-
fracture electron micrographs and X-ray diffraction patterns
indicate that the FDE liposomes are unilamellar vesicles.
3.6. Solvent residue
No organic solvent residue was found in FDE powder tested
by GC. This is an advantage compared with other liposome
technologies based on the emulsion method in which organic
solvents are usually removed by a rotary evaporation [7].
3.7. Storage stability
Liposomes were formed by rehydration of lyophilized
products that were stored protected from the light at 4 °C for
12 months without encapsulation or size change. Only the data
of PS/PC (1:9) FDE liposomes containing calcein with
lyoprotectants, sucrose and mannitol, are shown in Fig. 6.
4. Discussion
4.1. Formation mechanism of FDE liposomes
The above data have clearly demonstrated that the FDE
liposomes are spherical submicron unilamellar vesicles with a
relatively high encapsulation efficiency for both hydrophilic and
lipophilic agents. A schematic diagram of the processes that
might occur during the formation of FDE liposomes is illustrated
in Fig. 7. The initial emulsification and sonication of the aqueous
phase containing lyoprotectants and the organic phase in the
presence of the amphiphatic phospholipid molecules (panel a)
will produce submicron water droplets stabilized by a
phospholipid monolayer, namely W1/O type primary emulsions
(panel b). Such W1/O primary emulsions form into W1/O/W2
Fig. 4. X-ray diffraction patterns of lyophilized MLVs (sample 1), lyophilized LUVs (sample 2), lyophilized double emulsions (sample 3), lyophilized FDE liposomes
(sample 4) and a dispersion of lipids in sucrose matrix (sample 5). Only meaning parts of spectra (2-theta-scale from 1.0 to 5.0°) are shown. All the lyophilized products
were composed of PS/PC (1:9) with a mass ratio of sucrose to lipid of 5:1 as lyoprotectant.
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aqueous phase and emulsified (panel c). Submicron solid
spheres surrounded by a phospholipid bilayer with centripetal
and acentric polar heads are formed and vitrified when the
organic solvents are removed by freeze-drying (panel d). Such
submicron structures are confirmed by the X-ray diffraction
patterns shown in Fig. 4. In this procedure, carbohydrates act as
lyoprotectants as well as physical supports for the submicron
solid spherical structures. Upon rehydrationwithwater (panel e),
the submicron solid spheres (or dried liposomes) form into an
aqueous suspension of liposomes (panel f). The critical point in
this procedure is ensuring that theW1/O type primary emulsions
do not break up but form into stableW1/O/W2 double emulsions
and the submicron solid spherical structures do not collapse,
otherwise, the hydrophilic agents will not be encapsulated and
the liposome size and size distribution will increase enormously.
Therefore, the best possible lyoprotectants are necessary in the
freeze-drying process. When the calcein solution was used as
only the outer aqueous phase of W1/O/W2 double emulsions,Fig. 5. X-ray diffraction patterns of the samples of the powder of FDE composed o
Diffraction pattern b is the sample with sucrose as lyoprotectant together with mannalmost none of the calcein was incorporated into the vesicles.
This suggests that only the hydrophilic agents previously en-
trapped in the aqueous phase ofW1/O primary emulsions can be
incorporated into the final vesicles and further confirmed the
existence of the submicron solid spherical structures.
4.2. Influencing factors
It is obvious that a number of variables may be responsible
for determining the final products in terms of the FDE vesicle
size, structure, and encapsulation efficiency. These include
mainly the type of phospholipid and its solubility in the organic
solvents, lyoprotectants, and the loaded agents.
4.2.1. Lipids
When charged lipids are used to prepare liposomes, the
captured volume per mole lipid is increased due to electrostatic
repulsion of different parts of the charged membrane. Also, the
charged vesicles will repel each other thereby preventingf PS/PC (1:9). Diffraction pattern a is the sample with sucrose as lyoprotectant.
itol (1:1, w/w).
Fig. 6. The storage stability of the lyophilized products composed of PS/PC (1: 9) containing calcein and lyoprotectants sucrose and mannitol. The stability was
assessed by determination of the changes in encapsulation efficiency and mean diameters of the liposomes reconstituted by rehydration of lyophilized products
protected from light at 4 °C for different periods of time. (n=3).
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by leakage and an apparent size increase [27]. Thus, the charged
PS/PC (1:9) FDE liposomes are smaller in size than those
composed of PC alone, as can be seen in Table 1.
Cholesterol can reduce the fluidity of the membranes at
temperatures above the main phase transition temperature (Tm)
of the phospholipid [28]. It has been shown that cholesterolFig. 7. A schematic diagram of the formation of FDE liposomes. (a) The oil phase con
of W1/O emulsions. (c) The formation of W1/O/W2 double emulsions. (d) The forma
drying of W1/O/W2 double emulsions, and the lyoprotectants (sugar) act as physical
with water. “−” and “+” represent water molecules and oil molecules, respectively.‘dries' the lipid/water interface of membranes [29,30], thus
enhances close contact and van der Waals interactions between
adjacent lipid molecules, thereby contributing to the reduced
membrane permeability and prevention of leakage [30–32].
Although it has been shown that cholesterol-containing
liposomes exhibit multiple phase transitions when dehydrated,
the addition of trehalose will limit the phase separation of thetaining lipids and the aqueous phase containing lyoprotectants. (b) The formation
tion of submicron solid spheres surrounded by a phospholipid bilayer by freeze-
supports for the structure. (e and f) The formation of liposomes upon rehydration
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upon lyophilization [33]. Other studies have also shown that the
fatty acyl composition, cholesterol content and, with the
exception of phosphatidylglycerol, acid lipid content do not
significantly alter the retention of the aqueous contents by
vesicles dehydrated and rehydrated in the presence of trehalose
[34]. And it has been reported that different sugars almost
equally suppress the rise in Tm upon freeze-drying (at high
sugar/phospholipid ratios) and no distinct binding properties of
certain sugar molecules to the bilayer have been observed
[35,36]. As shown in Table 1, the cholesterol-containing FDE
liposomes with lyoprotectants of sucrose or lactose have a
higher encapsulation efficiency and larger size, which is
consistent with the above conclusions and the results obtained
with other methods [8,10]. These effects of cholesterol relate to
its molecular structure, weight and properties [37,38].
4.2.2. Agents and processes
The FDE liposomes have higher encapsulation efficiencies
for water-soluble calcein and 5-fluorouracil than those prepared
by other methods [23,39,40]. However, the encapsulation
efficiency of calcein (87%) is much higher than that of 5-
fluorouracil (19%).
With the FDE method, the water-soluble agent is first in the
dispersed phase (W1) of the W1/O emulsions, then in the inner
aqueous phase (W1) of the W1/O/W2 double emulsions,
subsequently trapped in the submicron solid spherical structures
by freeze-drying, and finally retained in the inner space of
liposomes following rehydration. Therefore, theoretically, the
initial agent-containing aqueous phase is always separated from
the outer aqueous phase by the lecithin-containing oil phase in
the double emulsions, which is advantageous for the mainte-
nance of a higher encapsulation efficiency of the water-soluble
agent compared with other solvent dispersion methods, such as
REV [8]. Later, the organic solvents in the oil phase are
removed by freeze-drying which will instantly ‘fix’ the agent in
the inner submicron phase or space surrounded by phospholi-
pids in the solidified matrix and then in the vitrification of
lyoprotectants. This is also advantageous for the maintenance of
a high encapsulation efficiency. With other liposome methods
based on W1/O/W2 emulsions, the organic solvents are usually
removed by evaporation at a relatively high temperature [7,41].
Thus, the inner aqueous solution as well as agents may leak out
by diffusion through the fluid oil phase. Furthermore, the
evaporation process might break down the double emulsions
and lead to drug loss.
However, the vesicle membrane fluidity and the physico-
chemical properties of the drug involved are also major factors
affecting the encapsulation efficiency of the liposomes [5,42].
One of the reasons for the rather low encapsulation efficiency of
5-fluorouracil is the fact that 5-fluorouracil could easily and
rapidly escape by diffusion through both the oil phase and the
lecithin bilayers, since it is neutral, has a low molecular weight
and a low partition coefficient between 1-octanol and water (log
Poctanol/water, −0.78). Also, the encapsulation efficiency of drug
correlates to some degree with its partition coefficient between
1-octanol and water [5,42,43].The encapsulation efficiencies of lipophilic agents are
usually rather high, since the lipophilic agents are intercalated
in the hydrophobic region between the double layers of the
phospholipids. These drugs do not leak out due to hydrophobic
interaction and, thus, a high encapsulation efficiency is
maintained [5,43,44]. This is the case for FDE vesicles which
exhibit an encapsulation efficiency of 93% for flurbiprofen.
4.2.3. Lyoprotectants
Disaccharides, such as trehalose, sucrose and lactose, are
lyoprotectants known to protect membranes from damage
during freeze-drying [45]. Water molecules associated with
polar head groups of hydrated phospholipid bilayers may be
replaced by sugar molecules which protect liposomes from
aggregation and fusion by holding individual vesicles in a
vitrified matrix and by reducing the surface tension at the
liposome surface during freeze-drying. At the same time, the
sugar molecules may prevent disruption of the bilayer by
maintaining the phospholipid in a fluid-like state to avoid
passage through the gel to the liquid-crystalline phase transition
[46–48]. These may also be reasonable explanations for the
effects of the lyoprotectants on the size and the encapsulation
efficiency of FDE vesicles which have similar or identical
structure to that of freeze-dried liposomes.
Mannitol has also been tentatively used as a lyoprotectant for
FDE liposomes, but had a much weaker protective effect (data
not shown) and no glass-forming properties revealed by X-ray
diffraction in Fig. 5. Mannitol encapsulated in liposomes has
been reported to localize in the aqueous core and show no
evidence of interaction with the lipid head groups [49]. This is
also a possible reason for its weaker lyoprotective effects and
this is consistent with our results. However, when mannitol
together with sucrose (1:1, w/w) was used as a lyoprotectant, the
lyoprotective effects were identical with those of sucrose and, in
addition, the lyophilized products possessed excellent loosen
features and could be very easily and rapidly rehydrated.
4.3. Others
Although no further research has been carried out on the
entrapment of FDE liposomes for the agents such as proteins,
peptides and nucleic acids, Szoka and Papahadjopoulos have
investigated the REV method, which is similar to FDE, and
found that alkaline phosphatase could be loaded and retained an
appreciable amount of activity (41%) after encapsulation and
the encapsulation efficiency is of 43% and 40% for poly(A) and
a 25s rRNA, respectively [8]. In fact, during the FDE procedure,
the water-soluble agents are always isolated from organic
solvents by amphiphilic phospholipid molecules, then freeze-
dried, and this may reasonably be used for the entrapment of
proteins, peptides and nucleic acids, which are rather suscep-
tible to organic solvents. Since the FDE method has the unique
advantages of removing organic solvents by freeze-drying and
allowing the preparation of stable dried products, this suggests
that the FDE method might also be an important technique for
the introduction of various pharmacological and biochemical
agents into biological systems both in vitro and in vivo.
230 T. Wang et al. / Biochimica et Biophysica Acta 1758 (2006) 222–231In addition, it should also be pointed out that the application
of the FDE procedure to remote loading of agents into
liposomes by the gradient method is possible and simple [50].
In conclusion, in this investigation, a novel liposome
preparation procedure based on double emulsions and lyoph-
ilization is described. It can be easily used to produce sterile
submicron liposomes with a relatively high encapsulation
efficiency for various agents. Because the liposomal drug can
be provided as a dry product, many of the problems associated
with aqueous liposome preparations can be avoided. Due to its
advantages, this approach is valid for the encapsulation of
agents in vesicles to form a product that may be suitable for the
efficient delivery of therapeutic agents.
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